- Package
- 1 g
- Purity
- 98%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 1156-19-0
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
1156-19-0
PubChem CID
5503
Molecular Formula
C14H21N3O3S
Molecular Weight
311.4 g/mol
Exact Mass
311.130363
InChIKey
OUDSBRTVNLOZBN-UHFFFAOYSA-N
IUPAC Name
1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
SMILES String
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2
Appearance
Tolazamide appears as white to off-white crystalline powder. Odorless or with a slight odor. (NTP, 1992)
Melting Point
17–173 °C
pKa
25
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Tolazamide (CAS 1156-19-0) is listed in the Inhibitors and Agonists portfolio, with molecular formula C14H21N3O3S and molecular weight 311. 40 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for biochemical and pharmacology research workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Nuclear factor NF-kappa-B p105 subunit (Homo sapiens) — 2 assays; Cytochrome P450 3A4 (Homo sapiens) — 2 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 2 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 2 assays; Alpha-2A adrenergic receptor (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Nuclear factor NF-kappa-B p105 subunit
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 4.75
Experimental evidence source: ChEMBL
Cytochrome P450 3A4
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 4.4
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 2A
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 2B
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
Alpha-2A adrenergic receptor
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Tolazamide is identified by CAS 1156-19-0, with molecular formula C14H21N3O3S, molecular weight 311.4, InChIKey OUDSBRTVNLOZBN-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Nuclear factor NF-kappa-B p105 subunit, Cytochrome P450 3A4, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, Alpha-2A adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.